Athanasios Georgas
Papers
1
Total Citations
12
H-Index
1
About
Dr. Athanasios Georgas is a pioneering ophthalmologist whose research centers on the intersection of radiation oncology and retinal disease, particularly neovascular age-related macular degeneration (nAMD). His landmark contribution is the STAR trial, a pivotal, double-masked, sham-controlled study evaluating stereotactic radiotherapy as a novel treatment for nAMD. This work demonstrated that precisely targeted ionizing radiation can mitigate key pathogenic processes underlying the disease, potentially reducing the burden of frequent anti-VEGF injections. With 12 citations since its 2024 publication, the STAR trial has already shaped clinical discourse, offering a paradigm-shifting approach to a leading cause of blindness. Dr. Georgas’s research addresses the critical unmet need for durable, non-invasive therapies, positioning him at the forefront of translational retinal therapeutics. His rigorous methodology—combining device innovation with gold-standard trial design—exemplifies how interdisciplinary science can transform patient care. For students and researchers, his work underscores the power of challenging treatment conventions through evidence-based innovation.
Research Focus
Key Achievements
Top Papers
- 1